Quaker Wealth Management
ABBV icon

Quaker Wealth Management’s AbbVie ABBV Stock Holding History

Quaker Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$255K Buy
976
+7
+0.7% +$1.8K 0.07% 65
2026
Q2 		$244K Buy
969
+12
+1% +$2.58K 0.07% 62
2026
Q1 		$208K Sell
957
-26
-3% -$5.77K 0.07% 65
2025
Q4 		$225K Sell
983
-19
-2% -$4.33K 0.07% 58
2025
Q3 		$232K Buy
1,002
+8
+0.8% +$1.63K 0.08% 60
2025
Q2 		$185K Buy
+994
New +$185K 0.06% 69
2024
Q3 		$203K Buy
+1,026
New +$191K 0.07% 59

Other funds holding ABBV

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Quaker Wealth Management's ABBV Position: Q3 2026 in Review

Quaker Wealth Management increased its AbbVie (ABBV) stake by 0.72% in Q3 2026, buying an estimated $1.8K and bringing the position to 976 shares worth $255K. The position accounts for 0.07% of the portfolio, ranked #65.

Quaker Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 2,418 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Quaker Wealth Management held 976 shares of AbbVie worth $255K as of Q3 2026.
  • Quaker Wealth Management bought 7 AbbVie shares in Q3 2026, an estimated $1.8K.
  • AbbVie made up 0.07% of Quaker Wealth Management's portfolio in Q3 2026, its #65 holding.
  • Quaker Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 2,418 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.